United States · FDA National Drug Code directory

Ropinirole

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 10135-673_441e0572-3413-1a21-e063-6294a90a8e6a
Product NDC: 10135-673
Form: TABLET, FILM COATED
Composition / generic term: ropinirole
Labeler: Marlex Pharmaceuticals Inc
Marketing category: ANDA
Marketing start / end (source format): 20190315
Source listing expiry: 20261231

Source-listed ingredients

ROPINIROLE HYDROCHLORIDE — .25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, FILM COATED in 1 BOTTLE (10135-673-01) · 10135-673-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →